Evidence map›Paper›PMID 26266539›Full record

ArticlePloS one2015

Molecular Evolution of PvMSP3α Block II in Plasmodium vivax from Diverse Geographic Origins.

Bhavna Gupta, B P Niranjan Reddy, Qi Fan, Guiyun Yan, Jeeraphat Sirichaisinthop, Jetsumon Sattabongkot, Ananias A Escalante, Liwang Cui

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Genetic diversity of theParasite epidemiology and control · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genetic diversity of the Plasmodium vivax phosphatidylinositol 3-kinase gene in two regions of the China-Myanmar border.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2018
    Article
  9. Article
  10. Article
  11. Microgeographically diverse Plasmodium vivax populations at the Thai-Myanmar border.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2016
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Bhavna GuptaDepartment of Entomology, Pennsylvania State University, University Park, PA 16802, United States of America.
B P Niranjan ReddyDepartment of Entomology, Pennsylvania State University, University Park, PA 16802, United States of America.
Qi FanDalian Institute of Biotechnology, Dalian, Liaoning, China.
Guiyun YanProgram in Public Health, University of California, Irvine, CA 92697, United States of America.
Jeeraphat SirichaisinthopVector Borne Disease Training Center, Pra Budhabat, Saraburi 18120, Thailand.
Jetsumon SattabongkotMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400 Thailand.
Ananias A EscalanteInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, United States of America.
Liwang CuiDepartment of Entomology, Pennsylvania State University, University Park, PA 16802, United States of America.
Pennsylvania State University · USMahidol University · THTemple University · USUniversity of California, Irvine · US

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Southeast Asia Malaria Research CenterU19AI089672 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CUI, LIWANG · 2010 to 2023
$28.9M
Evolution of Plasmodium vivax and Asian Macaque MalariasR01GM080586 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI ESCALANTE, ANANIAS ALBERTO · 2008 to 2011
$1.2M
NCATS NIH HHS UL1 TR001414NIAID NIH HHS U19 AI089672NIAID NIH HHS U19AI089672NIGMS NIH HHS GM080586NIGMS NIH HHS R01 GM080586
6 · The paper itself

Abstract

Block II of Plasmodium vivax merozoite surface protein 3α (PvMSP3α) is conserved and has been proposed as a potential candidate for a malaria vaccine. The present study aimed to compare sequence diversity in PvMSP3a block II at a local microgeographic scale in a village as well as from larger geographic regions (countries and worldwide). Blood samples were collected from asymptomatic carriers of P. vivax in a village at the western border of Thailand and PvMSP3α was amplified and sequenced. For population genetic analysis, 237 PvMSP3α block II sequences from eleven P. vivax endemic countries were analyzed. PvMSP3α sequences from 20 village-level samples revealed two length variant types with one type containing a large deletion in block I. In contrast, block II was relatively conserved; especially, some non-synonymous mutations were extensively shared among 11 parasite populations. However, the majority of the low-frequency synonymous variations were population specific. The conserved pattern of nucleotide diversity in block II sequences was probably due to functional/structural constraints, which were further supported by the tests of neutrality. Notably, a small region in block II that encodes a predicted B cell epitope was highly polymorphic and showed signs of balancing selection, signifying that this region might be influenced by the immune selection and may serve as a starting point for designing multi-antigen/stage epitope based vaccines against this parasite.

Indexed as

Evolution, MolecularAmino Acid SequenceAntigens, ProtozoanMolecular Sequence DataPlasmodium vivaxPolymorphism, GeneticProtozoan ProteinsAntigens, Protozoanmerozoite surface protein 3, PlasmodiumProtozoan Proteins

Identifiers

PMID26266539
PMCPMC4534382
OpenAlexW2212995955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.